HIV/AIDS

Understanding the Oncogenic Role of HIV in Burkitt Lymphoma

While the rate of certain HIV-linked non-Hodgkin lymphomas has declined since the introduction of ART, the incidence of Burkitt lymphoma has remained steady.
Neurocognitive Conditions Among People Living With HIV

Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
An Overview of HIV-Associated Neurocognitive Disorder

Rates of HIV-associated dementia have decreased from approximately 50% in the pre-cART era to 2% currently. However, roughly 50% of patients treated with cART have the milder forms of HIV-associated neurocognitive disorder (HAND).
AHA Guidelines for Prevention and Management of Cardiovascular Disease in HIV

A scientific statement from the American Heart Association was published in Circulation, with the purpose of providing a thorough review of available evidence on HIV-associated cardiovascular disease.
Improving HIV Prevention for Underserved, At-Risk Populations

This article describes the populations at high risk for HIV infection and reports the results of a collaborative, multifaceted educational intervention designed to reduce the documented disparities related to HIV care and prevention.

Latest News

HIV/AIDS

Kidney Disease May Add to Higher Risk for Cardiovascular Disease Due to HIV

The effect of HIV serostatus on brachial artery flow-mediated dilation strongly influenced by kidney function.

HIV/AIDS

Incidence and Clearance of High-Risk HPV in Gay and Bisexual Men

Bradley van Paridon

Investigators examined incidence, clearance, and risk factors for 13 high-risk human papilloma virus types in gay and bisexual men with HIV.

HIV/AIDS

NNRTI Ineffective Among Patients With Pretreatment HIV Drug Resistance

Jessica Nye, PhD

Authors conducted a systematic review and meta-analysis to assess the impact of PDR on treatment outcomes among people initiating NNRTI-based ART.

debunking the patient zero theory of AIDS

HIV/AIDS

Valganciclovir and Ganciclovir Effective for HIV-Associated CMVR in Low- and Middle-Income Countries

Estie Mermelstein, MSN, FNP-BC

The study authors describe the first use of valganciclovir treatment in lower-income countries for patients with CMVR, advanced HIV disease, and profound immunosuppression.

HIV/AIDS

IAS Panel Releases Updated 2020 Guidelines on ART and HIV Prevention

Brandon May

The International Antiviral Society published updated 2020 recommendations on use of antiretroviral therapy, laboratory monitoring and screening, prevention, and management of older patients living with HIV.

COVID19

Outcomes for HIV Patients Hospitalized with COVID-19

Bradley van Paridon

Study authors compared the presentation characteristics and outcomes of adults with and without HIV who were hospitalized with COVID-19.

HIV/AIDS

Cabotegravir Injection Can Protect Women From HIV for 2 Months

Experimental drug found to be 89% more effective at preventing HIV infection than Truvada.

Hepatitis

American College of Physicians Updates Best Practice Advice for Chronic HCV

Bradley van Paridon

Based on guidelines issued by the World Health Organizations in 2018, the American College of Physicians has issued best practice advice that simplifies and improves treatment of chronic hepatitis C virus.

HIV/AIDS

HIV, Hepatitis-B Drugs Proven to Reduce Risk of Type 2 Diabetes

Michelle Lampariello

Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.

HIV/AIDS

Women Show Higher INSTI-Associated Weight Gain and Incident Diabetes Mellitus Than Men

Zahra Masoud

Study authors investigated whether integrase strand transfer inhibitor treatment was associated with increased weight change from baseline and incident diabetes mellitus.

HIV/AIDS

PrEP Adherence Lower in Cisgender Women Compared to Cisgender Men

Zahra Masoud

Investigators sought to determine PrEP adherence in cisgender women compared to cisgender men, transgender women, transgender men, and non-binary patient populations.

HIV/AIDS

Positive Outlook on Telehealth for HIV care

Zahra Masoud

Study authors investigated patients’ perceptions to utilizing telehealth as an alternative for face-to-face in-person care, hoping to overcome barriers of patient retention such as transportation-related challenges, stigma, and fear of HIV status disclosure.

HIV/AIDS

Risk Factors for Weight Gain Following ART Initiation

Zahra Masoud

Study authors assessed various demographic, HIV-specific, and antiretroviral-therapy-specific risk factors associated with weight gain following initiation of antiretroviral therapy in patients with HIV.

HIV/AIDS

Switching From TDF to TAF or Dual-Therapy Regimens in HIV Patients

Zahra Masoud

Investigators conducted a prospective analysis in patients with HIV to assess the rate of switching from TDF-based to TAF-based or dual therapy regimens and to assess the impact of switching on eGFR.

HIV/AIDS

Well-Controlled HIV Infection Not Associated With Progression of Subclinical Atherosclerosis

Sweta Gupta

A major concern in people with HIV includes accelerated atherosclerosis, underlined by increased rates of coronary artery disease. Researchers investigated the longitudinal progression of atherosclerosis in persons with HIV vs without HIV in the Swiss population.

HIV/AIDS

Risk of Diabetes Mellitus in HIV Patients With Associated cART Initiation

Bradley van Paridon

Researchers assessed the risk of diabetes mellitus, weight gain, and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with HIV in the United States and Canada.

Hepatitis

Glecaprevir/Pibrentasvir Effective in Wide Range of Frail HCV Subpopulations

Sweta Gupta

Italian investigators conducted a prospective, multicenter study to assess the safety and effectiveness of glecaprevir/pibrentasvir in chronic hepatitis C patients and their subpopulations.